Our Products
Our offered Product range includes Gliclazide Modified Release Tablet, Glimepiride Tablets, Glibenclamide Tablets, Pioglitazone Tablets and Rosiglitazone Tablets.
Gliclazide modified release (MR) belongs to the class of medications called oral hypoglycemics. It is used for the control of blood glucose in people with type 2 diabetes.
It is used when diet, exercise, and weight reduction have not been found to control blood glucose well enough without medication.
Gliclazide MR increases the amount of insulin released by the pancreas and helps the body use insulin more efficiently.
Additional Information:
Payment Terms : T/T
Packaging Details : 10 x 10 tablets in Blisters are packed in a mono carton.
Delivery Time : 8-20 days
CAS NO:93479-97-1
Glimepiride is a medium- to long-acting sulfonylurea antidiabetic drug.Glimepiride is indicated to treat type 2 diabetes mellitus; its mode of action is to increase insulin production by the pancreas.
CAS NO:112529-15-4
Pioglitazone is used along with a proper diet and exercise program to control high blood sugar in patients with type II diabetes.
Pioglitazone is a prescription drug of the class thiazolidinedione (TZD) with hypoglycemic (anti hyperglycemic, antidiabetic) action to treat diabetes. It is used to improve glucose control in adults over the age of 18 with type 2 diabetes.
Rosiglitazone combined with diet, exercise, weight control, and cessation of smoking is used for treating type II diabetes.